CT Surgeon | Resident | Medical Student | In the News
 
     
« Back to Program
 
VAD/ECMO
VAD/ECMO Session
Tuesday, April 28, 2015 | 7:00 AM - 8:40 AM
Moderators: *Michael A. Acker & *Anelechi C. Anyanwu
 
37. Concomitant Aortic Valve Repair in Patients Undergoing Continuous-flow Left Ventricular Assist Device Placement: A 10-year Experience and Clinical Implications
Shinichi Fukuhara, Koji Takeda, Jiho Han, Luilly Vargas, Boyangzi Kat Li1Melana Yuzefpolskaya, Donna M. Mancini, Paolo C. Colombo, Veli Topkara, *Paul A Kurlansky, Hiroo Takayama, *Yoshifumi Naka
Columbia University, New York, NY
View Slides
View Abstract
 
38. A Novel and Validated PracticalRisk Score to Predict the Need for Right Ventricular Assist Device at the Timeof Continue-Flow Left Ventricular Assist Device Implantation
Steve K. Singh, Rohan M. Shah, Jatin Anand, *William E. Cohn, Leo Simpson, Andrew Civitello, Hari R. Mallidi
Baylor College of Medicine, Houston, TX
View Slides
View Abstract
 
39. Ipsilateral Lower Extremity Complications in Patients Undergoing Emergent Common Femoral Arteriovenous Extracorporeal Membrane Oxygenator therapy
Prashanth Vallabhajosyula1, Matthew Kramer1, Sofiane Lazar1, *Wilson Y. Szeto2, Pavan Atluri1, J. Eduardo Rame1, Joyce W. Wald1, Kathryn Gray1, Nimesh Desai1, *Michael A. Acker1
1University of Pennsylvania, Philadelphia, PA; 2Penn Presbyterian Hospital, Philadelphia, PA
View Slides
View Abstract
 
40. A Decade of Experience with Over 300 Continuous-Flow Left Ventricular Assist Devices at a Single Center
*Ranjit John, Peter Eckman, Chris Holley, Samit Roy, Laura Harvey, Kaustav Majumder, *Sara Shumway, *Kenneth Liao
University of Minnesota, Minneapolis, MN
View Slides
View Abstract
 
41. Risk Factors for Development of Tricuspid Regurgitation post Heart Transplantation and Long-term Outcome of Tricuspid Valve Surgery
Anja Claudia Baier, Eva Maria Delmo Walter, Roland Hetzer
Deutsches Herzzentrum Berlin, Berlin, Germany
View Slides
View Abstract
 
42. A Multi-Institutional Comparison of Adverse Events in Contemporary Continuous-Flow Left Ventricular Assist Devices: Do Significant Differences Exist?
John M. Stulak1, Mary Elizabeth Davis2, Nicholas Haglund2, Shannon Dunlay1, Jennifer Cowger3, Palak Shah4, *Francis Pagani5, Keith Aaronson5, Simon Maltais2
1Mayo Clinic, Rochester, MN; 2Vanderbilt Heart and Vascular Institute, Nashville, TN; 3St. Vincent's Hospital, Indianapolis, IN; 4Inova Fairfax Hospital, Falls Church, VA; 5University of Michigan, Ann Arbor, MI
View Slides
View Abstract
 
43. Impact of Periportal Fibrosis without Cirrhosis on Outcome Following continuous Flow Left Ventricular Assist Device Implantation
Jonathon E. Sargent, Todd F. Dardas, Jason W. Smith, Richard K. Cheng, Sophia Carolina Masri, Kent R. Shively, Lauren M. Colyer, Nahush A. Mokadam
University of Washington, Seattle, WA
View Slides
View Abstract
 
44. Severe Pulmonary Hypertension in Patients Undergoing Leftventricular Assist Device Insertion as Bridge to Transplant
Masaki Tsukashita, Hiroo Takayama, Koji Takeda, Paolo C. Colombo, Veli K. Topkara, Melana Yuzefpolskaya, Donna M. Mancini, *Yoshifumi Naka
New York Presbyterian Hospital/Columbia University, New York, NY
View Slides
View Abstract
 
45. Lung Transplantation and Concomitant Cardiac Surgery: Is It Justified?
Reshma M. Biniwale, *David Ross, Curtis Hunter, Jamil Aboulhosn, Oh-Jin Kwon, David Gjertson, *Abbas Ardehali
University of California, Los Angeles, CA
View Slides
View Abstract
 
AATS Guidelines: Bridge to Transplant & Extracorporeal Lung Support
*Marcelo Cypel, Toronto General Hospital, Toronto, ON, Canada
View Slides
 
8:40 p.m. ADJOURN
 


* AATS Member
 
We Model Excellence
Follow AATS on YouTube Follow AATS on Facebook
Copyright © 2015 American Association for Thoracic Surgery
All rights reserved. IMPORTANT REMINDER: The preceding information is intended only to provide general guidance and not as a definitive basis for diagnosis or treatment in any particular case. It is very important that you consult a doctor about any specific medical problem or question.